Active, Not Recruiting Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma NCT06898970 Conditions Angiosarcoma, Angiosarcoma, Adult, Hemangiosarcoma, +5 more Locations University of California, San Francisco — San Francisco, California, United States View Trial Details
